CHEMOSENSITIZING EFFECTS OF CROMOLYN IN GLIOBLASTOMA CELLS VIA TRANSGLUTAMINASE 2 AND FERROPTOSIS SIGNALING

Alp KARAASLAN, Ceyhan HACIOGLU, Burak OZDEMIR

Journal of Clinical Trials and Experimental Investigations - 2026;5(3):0-0

Istanbul Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital, Department of Neurosurgery, Istanbul, Türkiye

 

Objective: Glioblastoma (GBM) remains a therapeutic challenge due to inherent and acquired resistance to temozolomide (TMZ). This study investigated the chemosensitizing potential of cromolyn, a mast cell stabilizer with emerging anti-cancer properties, focusing on its interaction with transglutaminase 2 (TGM2) and ferroptosis signaling. Materials and methods: We hypothesized that cromolyn could overcome TMZ resistance by inhibiting TGM2 and activating ferroptotic cell death. Using human GBM cell lines (U87, U251, T98G) and a TMZ-resistant derivative (U87-R), we assessed cell viability (CCK-8), clonogenic survival, and protein/gene expression (Western blot, qRT-PCR, ELISA). TGM2 was silenced via siRNA. Ferroptosis was evaluated by measuring lipid peroxidation (C11-BODIPY??¹/??¹, MDA), GSH, GPX4, and ACSL4 levels. Intracellular labile iron pool and reactive oxygen species were quantified using FerroOrange and dihydroethidium (DHE) staining, respectively. Results: TGM2 expression was elevated in TMZ-resistant U87-R cells. Cromolyn exhibited time- and concentration-dependent cytotoxicity in both parental and resistant cells, with higher IC?? values in the resistant line. Cromolyn treatment downregulated TGM2 expression and, in combination with TMZ, significantly enhanced lipid peroxidation, depleted GSH, suppressed GPX4, and upregulated ACSL4. This was accompanied by increased labile iron and ROS levels. The enhanced cytotoxic effect of TMZ and cromolyn co-treatment was rescued by ferroptosis inhibitors and iron chelation (DFO), but not by apoptosis or necroptosis inhibitors. Furthermore, cromolyn's effect on GPX4 was partially reversed by the proteasome inhibitor MG132. TGM2 silencing similarly sensitized resistant cells to TMZ. Conclusion: These findings suggest that cromolyn enhances TMZ sensitivity in resistant GBM cells in association with TGM2 modulation and ferroptosis signaling, without establishing TGM2 suppression as the definitive causal mechanism.